Susquehanna Fundamental Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,125
Closed -$381K 142
2023
Q3
$381K Sell
3,125
-84,131
-96% -$11.2M 0.02% 283
2023
Q2
$12.3M Hold
87,256
0.45% 62
2023
Q1
$12.3M Sell
87,256
-44,680
-34% -$6.39M 0.29% 99
2022
Q4
$20.6M Buy
131,936
+81,938
+164% +$11.8M 0.36% 65
2022
Q3
$6.13M Buy
+49,998
New +$6.58M 0.1% 272
2022
Q1
$1.66M Sell
12,100
-6,800
-36% -$948K 0.03% 653
2021
Q4
$3.27M Sell
18,900
-300
-2% -$45.6K 0.09% 294
2021
Q3
$2.79M Buy
19,200
+6,800
+55% +$995K 0.05% 490
2021
Q2
$1.64M Buy
+12,400
New +$1.62M 0.03% 669
2021
Q1
Sell
-142,804
Closed -$17M 1549
2020
Q4
$17M Buy
142,804
+124,006
+660% +$15.1M 0.31% 70
2020
Q3
$2.15M Buy
+18,798
New +$2.22M 0.06% 411
2020
Q1
Sell
-65,400
Closed -$6.98M 329
2019
Q4
$6.98M Hold
65,400
0.91% 20
2019
Q3
$7M Buy
65,400
+14,000
+27% +$1.44M 0.85% 29
2019
Q2
$5.23M Buy
51,400
+600
+1% +$57.7K 0.61% 50
2019
Q1
$4.57M Buy
+50,800
New +$4.4M 0.52% 63

Other funds holding DGX

Susquehanna Fundamental Investments's DGX Position: Q4 2023 in Review

Susquehanna Fundamental Investments sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 3,125 shares — an estimated $381K sold.

Susquehanna Fundamental Investments first reported a position in DGX in Q1 2019 and held it in 15 quarters. The position peaked at $20.6M in Q4 2022. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Susquehanna Fundamental Investments reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,125 Quest Diagnostics shares in Q4 2023, an estimated $381K.
  • Susquehanna Fundamental Investments first reported a position in Quest Diagnostics in Q1 2019 and held it in 15 quarters.
  • Susquehanna Fundamental Investments's Quest Diagnostics position peaked at $20.6M in Q4 2022.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2023, filed 14 Feb 2024.